OptimizeRx CorporationOPRXNASDAQ
Loading
Enterprise value to EBITDA ratio
5Y CAGR
-54.2%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 14.05 | +215.0% |
| 2024 | -12.22 | +2.8% |
| 2023 | -12.58 | +57.8% |
| 2022 | -29.82 | -107.0% |
| 2021 | 423.69 | -39.4% |
| 2020 | 698.68 | +985.0% |
| 2019 | -78.95 | -184.7% |
| 2018 | 93.17 | +509.0% |
| 2017 | -22.78 | -74.4% |
| 2016 | -13.06 | - |